Industry – academia partnerships: way to go for anticancer drug development?
Industry – academia partnerships are increasingly growing in an effort to make the drug discovery process more efficient. In a Cancer Research UK perspective, several industrial collaborations are outlined with an eye on the distinct but com-plementary expertise brought about in anti-cancer drug development.
For more industry – academia initiatives check out
GlaxoSmithKline’s Discovery Fast Track competition for academic researchers
Eli Lilly’s Open Innovation Platform
Marie Curie’s Industry-Academia Partnerships and Pathways (IAPP)
Read another article on industry – academia partnerships from Science Magazine and an older article from this blog on the topic here.